INT93764

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.36
First Reported 2001
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 1.79
Pain Relevance 2.07

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

nucleus (GRHL3) DNA binding (GRHL3)
GRHL3 (Homo sapiens)
Pain Link Frequency Relevance Heat
Somatostatin 9 100.00 Very High Very High Very High
antagonist 3 100.00 Very High Very High Very High
bradykinin 2 96.20 Very High Very High Very High
IPN 1 95.76 Very High Very High Very High
qutenza 2 93.08 High High
nociceptor 9 91.84 High High
agonist 3 91.76 High High
Central nervous system 4 89.28 High High
Pain 5 84.00 Quite High
dorsal root ganglion 1 80.08 Quite High
Disease Link Frequency Relevance Heat
Hemorrhage 22 100.00 Very High Very High Very High
Toxicity 25 96.96 Very High Very High Very High
Inflammatory Pain 1 95.76 Very High Very High Very High
Nociception 3 88.32 High High
Ganglion Cysts 1 80.08 Quite High
Pain 5 64.60 Quite High
Drug Induced Neurotoxicity 1 59.88 Quite High
INFLAMMATION 1 54.84 Quite High
Reprotox - General 1 10 50.00 Quite Low
Diarrhoea 12 14.64 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Each of these actions can be reversed following co-injection of OCT with the SSTR antagonist cyclo-somatostatin (c-SOM).
SOM Binding (co-injection) of associated with antagonist and somatostatin
1) Confidence 0.36 Published 2001 Journal Pain Section Abstract Doc Link 11207395 Disease Relevance 0.43 Pain Relevance 1.14
This occurs through local activation of SSTRs in the injected hindpaw and is reversed following co-application of the SSTR antagonist cyclo-somatostatin (c-SOM).
SOM Binding (co-application) of associated with antagonist and somatostatin
2) Confidence 0.36 Published 2004 Journal Pain Section Abstract Doc Link 15288402 Disease Relevance 0.14 Pain Relevance 0.93
Escalated patients required more medical interventions for bleeding (LENT/SOM bleeding management), but the difference was not statistically significant: by 5 years, 17 escalated patients had required ?
SOM Binding (management) of associated with hemorrhage
3) Confidence 0.36 Published 2010 Journal International Journal of Radiation Oncology, Biology, Physics Section Body Doc Link PMC2937212 Disease Relevance 1.21 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox